Skip to main content
. 2019 Oct 30;25(4):563–575. doi: 10.5056/jnm18194

Table 1.

Characteristics of the Patients

Variable Placebo Magnesium oxide P-value
Sex (male/female) 0/16 0/17
Age (yr) 42.9 ± 12.7 39.0 ± 12.9 0.271
Height (cm) 159.6 ± 5.1 157.4 ± 6.4 0.357
Weight (kg) 56.4 ± 10.1 54.0 ± 8.6 0.471
BMI 22.1 ± 3.3 21.7 ± 2.6 0.986
Alcohol 2 (12.5) 1 (5.9) 0.601
Smoking 9 (56.3) 9 (52.9) > 0.999
SBM (n/wk) 2.5 ± 1.0 1.8 ± 1.1 0.067
CSBM (n/wk) 1.3 ± 1.6 0.8 ± 1.3 0.323
BSFS score 2.3 ± 1.1 1.8 ± 0.6 0.221
Colon transit time (hr) 46.4 ± 36.9 75.5 ± 37.3 0.036
Abdominal bloating (score) 2.1 ± 1.1 2.2 ± 1.1 0.673
Abdominal discomfort (score) 1.9 ± 1.2 1.9 ± 0.9 0.863
Straining (score) 2.0 ± 1.1 2.0 ± 1.0 > 0.999
Sensation of incomplete evacuation (score) 1.6 ± 0.8 2.1 ± 1.1 0.150
SF-8 physical component summary (score) 52.1 ± 4.9 50.6 ± 4.6 0.390
SF-8 mental component summary (score) 48.5 ± 6.5 47.8 ± 5.5 0.771
JPAC-QOL (score) 20.3 ± 11.7 30.1 ± 13.0 0.035
Constipation scoring system (score) 8.9 ± 3.9 12.5 ± 3.7 0.014

BMI, body mass index; SBM, spontaneous bowel movement; CSBM, complete spontaneous bowel movement; SF-8, short form-8; JPAC-QOL, the Japanese version of the patient assessment of constipation quality of life.

Data are presented as n, mean ± SD, or n (%).